Medivir to present at the Redeye Fight Cancer Day
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day on January 19, 2023. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox) at 13.35 CET. The presentation is live broadcasted and can be followed at the event page;https://www.redeye.se/events/868559/redeye-theme-fight-cancer The presentation will be